Charles Darwin University

CDU eSpace
Institutional Repository

CDU Staff and Student only

Depression and diabetes: Treatment and health-care delivery

Petrak, Frank, Baumeister, Harald, Skinner, Timothy, Brown, Alex and Holt, Richard I. G. (2015). Depression and diabetes: Treatment and health-care delivery. The Lancet Diabetes & Endocrinology,3(6):475-485.

Document type: Journal Article
Citation counts: Altmetric Score Altmetric Score is 30
Google Scholar Search Google Scholar

IRMA ID 84377429xPUB42
Title Depression and diabetes: Treatment and health-care delivery
Author Petrak, Frank
Baumeister, Harald
Skinner, Timothy
Brown, Alex
Holt, Richard I. G.
Journal Name The Lancet Diabetes & Endocrinology
Publication Date 2015
Volume Number 3
Issue Number 6
ISSN 2213-8587   (check CDU catalogue open catalogue search in new window)
eISSN 2213-8595
Scopus ID 2-s2.0-84929956031
Start Page 475
End Page 485
Total Pages 11
Place of Publication United Kingdom
Publisher The Lancet Publishing Group
HERDC Category C1 - Journal Article (DIISR)
Abstract Despite research efforts in the past 20 years, scientific evidence about screening and treatment for depression in diabetes remains incomplete and is mostly focused on North American and European health-care systems. Validated instruments to detect depression in diabetes, although widely available, only become effective and thus recommended if subsequent treatment pathways are accessible, which is often not the case. Because of the well known adverse effects of the interaction between depression and diabetes, treatment goals should focus on the remission or improvement of depression as well as improvement in glycaemic control as a marker for subsequent diabetes outcome. Scientific evidence evaluating treatment for depression in type 1 and type 2 diabetes shows that depression can be treated with moderate success by various psychological and pharmacological interventions, which are often implemented through collaborative care and stepped-care approaches. The evidence for improved glycaemic control in the treatment of depression by use of selective serotonin reuptake inhibitors or psychological approaches is conflicting; only some analyses show small to moderate improvements in glycaemic control. More research is needed to evaluate treatment of different depression subtypes in people with diabetes, the cost-effectiveness of treatments, the use of health-care resources, the need to account for cultural differences and different health-care systems, and new treatment and prevention approaches.
DOI   (check subscription with CDU E-Gateway service for CDU Staff and Students  check subscription with CDU E-Gateway in new window)
Version Filter Type
Access Statistics: 221 Abstract Views  -  Detailed Statistics
Created: Tue, 31 Mar 2015, 14:43:44 CST by Marion Farram